Changeflow GovPing Pharma & Drug Safety Patent Application for Chromophores with New Ri...
Routine Notice Added Draft

Patent Application for Chromophores with New Ring-Locked Donors

Favicon for changeflow.com ChangeBridge: Patent Apps - Organic Chemistry (C07D)
Published September 23rd, 2025
Detected March 26th, 2026
Email

Summary

The USPTO has published a new patent application (US20260085189A1) filed by Lightwave Logic, Inc. The application describes novel nonlinear optical (NLO) chromophores with ring-locked donors designed to increase r33 and stability. The filing date was September 23, 2025.

What changed

This document is a publication of a patent application filed with the USPTO, specifically application number US20260085189A1, assigned to Lightwave Logic, Inc. The application details new nonlinear optical (NLO) chromophores featuring ring-locked donors, which are intended to enhance r33 values and stability. The abstract outlines the general structure of these chromophores, including variations for R1, R2, and the number of donating groups (n).

As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on regulated entities. However, it signifies potential future intellectual property developments in the field of NLO materials, which could impact companies involved in advanced optical technologies, telecommunications, or specialized chemical manufacturing. Companies operating in these sectors may wish to monitor the progress of this patent application and related filings.

Source document (simplified)

← USPTO Patent Applications

Chromophores with New Ring-Locked Donors that Increase r33 and Stability

Application US20260085189A1 Kind: A1 Mar 26, 2026

Assignee

Lightwave Logic, Inc.

Inventors

Ginelle A. Ramann, Barry L. Johnson, Harvey F. Fulo, Will D. Mikkelsen-Yi

Abstract

The present disclosure is directed, in general, to nonlinear optical (NLO) chromophores comprising donating groups of the following general structure (D1): where R1 can be a substituted or unsubstituted aryl or a substituted or unsubstituted alkyl. R2 can be a substituted or unsubstituted aryl, a substituted or unsubstituted alkyl or a ring-locked structure. In some embodiments, R1 and R2 can together form a ring structure. In some embodiments, R2 can be a ring-locked structure forming a ring with the phenyl group of the formula (D1). In certain embodiments, n is 1 or 2.

CPC Classifications

C09B 23/0091 C07D 307/68 C07F 7/1804 C09B 67/0063 G02F 1/3558 G02F 1/361 C09K 2211/1007 C09K 2211/1011 C09K 2211/1014 C09K 2211/1018

Filing Date

2025-09-23

Application No.

19337534

View original document →

Named provisions

Abstract

Classification

Agency
USPTO
Published
September 23rd, 2025
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260085189A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies Technology companies
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing 5112 Software & Technology
Activity scope
Research and Development Intellectual Property Management
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Technology

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Apps - Organic Chemistry (C07D) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.